- Home
- PHAR vs IIM Comparison
PHAR vs IIM Comparison
Compare PHAR & IIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- IIM
- Stock Information
- Founded
- PHAR 1988
- IIM 1993
- Country
- PHAR Netherlands
- IIM United States
- Employees
- PHAR 382
- IIM N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- IIM Investment Managers
- Sector
- PHAR Health Care
- IIM Finance
- Exchange
- PHAR Nasdaq
- IIM Nasdaq
- Market Cap
- PHAR 679.0M
- IIM 582.9M
- IPO Year
- PHAR N/A
- IIM N/A
- Fundamental
- Price
- PHAR $9.98
- IIM $12.00
- Analyst Decision
- PHAR Strong Buy
- IIM
- Analyst Count
- PHAR 3
- IIM 0
- Target Price
- PHAR $27.00
- IIM N/A
- AVG Volume (30 Days)
- PHAR 5.9K
- IIM 122.2K
- Earning Date
- PHAR 03-13-2025
- IIM 01-01-0001
- Dividend Yield
- PHAR N/A
- IIM 4.63%
- EPS Growth
- PHAR N/A
- IIM N/A
- EPS
- PHAR N/A
- IIM 0.02
- Revenue
- PHAR $285,745,000.00
- IIM N/A
- Revenue This Year
- PHAR $20.08
- IIM N/A
- Revenue Next Year
- PHAR $9.22
- IIM N/A
- P/E Ratio
- PHAR N/A
- IIM $591.50
- Revenue Growth
- PHAR 30.64
- IIM N/A
- 52 Week Low
- PHAR $6.65
- IIM $9.94
- 52 Week High
- PHAR $13.20
- IIM $12.32
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- IIM 47.08
- Support Level
- PHAR $9.37
- IIM $11.92
- Resistance Level
- PHAR $10.15
- IIM $12.05
- Average True Range (ATR)
- PHAR 0.50
- IIM 0.12
- MACD
- PHAR -0.09
- IIM 0.03
- Stochastic Oscillator
- PHAR 57.53
- IIM 69.18
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About IIM Invesco Value Municipal Income Trust
Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income which is exempt from federal income tax.